Clinical data | |
---|---|
Trade names | Ovalyse |
Other names | TAP-031; U-69689; 9-(N-Ethyl-L-prolinamide)-10-deglycinamide; 9-(N)-Et-ProNH2-10-des-GlyNH2-LHRH; Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-NHEt |
Drug class | GnRH analogue; GnRH agonist; Antigonadotropin |
ATCvet code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.164.570 |
Chemical and physical data | |
Formula | C55H76N16O12 |
Molar mass | 1153.313 g·mol−1 |
3D model ( JSmol) | |
| |
|
Fertirelin, or fertirelin acetate, sold under the brand name Ovalyse, is a gonadotropin-releasing hormone agonist (GnRH agonist) which has been marketed in the United Kingdom and Austria. [1] [2] [3] It may no longer be available. [4] Fertirelin has been used in veterinary medicine. [2] It may have been used in the treatment of sex hormone-dependent conditions and infertility in women. [3] The drug was first introduced in 1981 in Japan to treat various kinds of ovarian failure in cattle. [5] Fertirelin is a synthetic peptide and GnRH analogue. [1] [2] It is used as the acetate salt. [2]